Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT00165256
PHASE2
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Sponsor: Dana-Farber Cancer Institute
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.
Official title: Wide Excision Alone for DCIS-Grades 1 and 2
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
158
Start Date
1995-05
Completion Date
2027-12
Last Updated
2025-12-29
Healthy Volunteers
No
Conditions
Interventions
OTHER
Observation
Wide excision of DCIS and a minimum of 1cm histologically negative margin of breast tissue
Locations (2)
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States